Find the following Ratios:

A) Current Ratio

B) Quick Ratio

C) Operating Ratio

D) Return on total assets

Please show all of the work.

United Health Group Consolidated Balance Sheets December 31, 2020 December 31, 2019 $ 16,921 $ 10,985 2,860 3,260 12,870 11,822 12,534 9,640 4,076 3,076 4,457 3,851 53,718 42,634 41,242 37,209 8,626 8,704 71,337 65,659 10,856 10,349 11,510 9,334 $ 197,289 $ 173,889 (in millions, except per share data) Assets Current assets: Cash and cash equivalents. Short-term investments ... Accounts receivable, net of allowances of $990 and $519 Other current receivables, net of allowances of $1,047 and $859 Assets under management Prepaid expenses and other current assets Total current assets Long-term investments Property, equipment and capitalized software, net of accumulated depreciation and amortization of $5,230 and $4,995 Goodwill ..... Other intangible assets, net of accumulated amortization of $5,455 and $5,072 Other assets Total assets Liabilities, redeemable noncontrolling interests and equity Current liabilities: Medical costs payable Accounts payable and accrued liabilities Short-term borrowings and current maturities of long-term debt Unearned revenues Other current liabilities Total current liabilities Long-term debt, less current maturities Deferred income taxes.. Other liabilities Total liabilities Commitments and contingencies (Note 12) Redeemable noncontrolling interests Equity: Preferred stock, $0.001 par value 10 shares authorized; no shares issued or outstanding Common stock, $0.01 par value 3,000 shares authorized; 946 and 948 issued and outstanding Additional paid-in capital Retained earnings Accumulated other comprehensive loss Nonredeemable noncontrolling interests Total equity Total liabilities, redeemable noncontrolling interests and equity 21,872 $ 21,690 22,495 19,005 4,819 3,870 2,842 2,622 20,392 14,595 72,420 61,782 38,648 36,808 3,367 2,993 12,315 10,144 126,750 111,727 2,211 1,726 10 69,295 (3,814) 2,837 68,328 $ 197,289 9 7 61,178 (3,578) 2,820 60,436 $ 173,889 United Health Group Consolidated Statements of Cash Flows For the Years Ended December 31, 2020 2019 2018 $ 15,769 $ 14,239 $ 12,382 2,891 (8) 679 (52) 2,720 230 697 (106) 2,428 42 638 (71) (688) (2,195) 152 5,348 278 162 (1,563) 1,221 733 130 18,463 (1,351) (750) 1,831 526 38 15,713 22,174 in millions) Operating activities Net earnings Noncash items: Depreciation and amortization Deferred income taxes Share-based compensation Other, net Net change in other operating items, net of effects from acquisitions and changes in AARP balances: Accounts receivable Other assets Medical costs payable Accounts payable and other liabilities Unearned revenues Cash flows from operating activities Investing activities Purchases of investments Sales of investments Maturities of investments Cash paid for acquisitions, net of cash assumed Purchases of property, equipment and capitalized software Other, net Cash flows used for investing activities Financing activities Common share repurchases Cash dividends paid Proceeds from common stock issuances Repayments of long-term debt Proceeds from (repayments of) short-term borrowings, net Proceeds from issuance of long-term debt Customer funds administered. Other, net Cash flows used for financing activities Effect of exchange rate changes on cash and cash equivalents Increase (decrease) in cash and cash equivalents Cash and cash equivalents, beginning of period Cash and cash equivalents, end of period Supplemental cash flow disclosures Cash paid for interest ... Cash paid for income taxes (16,577) (18,131) (14,010) 6,489 8,536 3,641 7,252 7,091 6,270 (7,139) (8,343) (5,997) (2,051) (2,071) (2,063) (506) 219 (226) (12,532) (12,699) (12,385) (4,250) (5,500) (4,500) (4,584) (3,932) (3,320) 1,440 1,037 838 (3,150) (1,750) (2.600) 872 300 (201) 4,864 5,444 6,935 1,677 13 (131) (459) (1,237) (1,386) (3,590) (5,625) (4,365) (116) (20) (78 5,936 119 (1,115) 10,985 10,866 11,981 $ 16,921 $ 10,985 $ 10,866 $ 1,704 4,935 $ 1,627 3,542 $ 1,410 3.257 521 United Health Group Consolidated Statements of Changes in Equity Accumulated Other Comprehensive (Loss) Income Net Unrealized Foreign Additional (Losses) Common Stock Currency Nonredeemable Paid-In Retained Gains on Translation Noncontrolling Total (in millions Shares Amount Capital Earnings Investments Losses Interests Equity Balance at January 1, 2018 969 $ 10 $ 1,703 $48,730 $ (13) $ (2,654) $ 2,057 $ 49,833 Adjustment to adopt ASU 2016-01 (24) 24 Net earnings 11.986 273 12.259 Other comprehensive loss (275) (1,242) (1,517) Issuances of common stock, and related tax effects 10 814 814 Share-based compensation 620 620 Common share repurchases (19) (2,974) (1,526) (4,500) Cash dividends paid on common shares ($3.45 per share) (3,320) (3.320) Redeemable noncontrolling interest fair value and other adjustments (163) (163) Acquisition and other adjustments of nonredeemable noncontrolling interests 521 Distributions to nonredeemable noncontrolling interest (228) (228) Balance at December 31, 2018 960 10 55,846 (264) (3,896) 2,623 54,319 Adjustment to adopt ASU 2016-02 (13) (5) (18) Net earnings 13,839 285 14,124 Other comprehensive income (loss) 853 (271) 582 Issuances of common stock, and related tax effects 10 696 696 Share-based compensation 673 673 Common share repurchases (22) (1) (937) (4,562) (5.500) Cash dividends paid on common shares ($4.14 per share) (3.932) (3,932) Redeemable noncontrolling interest fair value and other adjustments (316) (316) Acquisition and other adjustments of nonredeemable noncontrolling interests (109) 196 87 Distributions to nonredeemable noncontrolling interest (279) (279) Balance at December 31, 2019 948 9 7 61,178 589 (4.167) 2,820 60,436 Adjustment to adopt ASU 2016-13 (28) (28) Net earnings 15,403 254 15,657 Other comprehensive income (loss) 747 (983) (236) Issuances of common stock, and related tax effects 12 1 1,119 1,120 Share-based compensation 647 647 Common share repurchases (14) (1,576) (2,674) (4,250) Cash dividends paid on common shares ($4.83 per share) (4,584) (4,584) Redeemable noncontrolling interests (197) fair value and other adjustments ... (197) Acquisition and other adjustments of nonredeemable noncontrolling interests 40 40 Distributions to nonredeemable noncontrolling interests (277) (277) Balance at December 31, 2020 946 $ 10 $ $ 69,295 $ 1,336 $ (5,150) 2.837 $ 68,328 United Health Group Consolidated Statements of Comprehensive Income For the Years Ended December 31, in millions 2020 2019 2018 Net earnings $15,769 $14,239 $12,382 Other comprehensive (loss) income: Gross unrealized gains (losses) on investment securities during the period ... 1,058 1,212 (294) Income tax effect (253) (279) Total unrealized gains (losses), net of tax 805 933 (227) Gross reclassification adjustment for net realized gains included in net earnings ... (75) (104) (62) Income tax effect 17 24 14 Total reclassification adjustment, net of tax (58) (80) (48 Total foreign currency translation losses (983) (271) (1,242) Other comprehensive (loss) income (236) 582 (1,517) Comprehensive income .... 15,533 14,821 10,865 Comprehensive income attributable to noncontrolling interests (366) (400) (396) Comprehensive income attributable to United Health Group common shareholders $15,167 $14,421 $10,469 United Health Group Consolidated Statements of Operations For the Years Ended December 31, 2020 2019 2018 $201,478 $189,699 $178,087 34,145 31,597 29,601 20,016 18,973 17,183 1,502 1,886 1,376 257,141 242,155 226,247 in millions, except per share data) Revenues: Premiums Products Services Investment and other income Total revenues Operating costs: Medical costs Operating costs Cost of products sold Depreciation and amortization Total operating costs Earnings from operations Interest expense Earnings before income taxes Provision for income taxes Net earnings Earnings attributable to noncontrolling interests Net earnings attributable to United Health Group common shareholders.. Earnings per share attributable to United Health Group common shareholders: Basic Diluted Basic weighted-average number of common shares outstanding Dilutive effect of common share equivalents Diluted weighted-average number of common shares outstanding Anti-dilutive shares excluded from the calculation of dilutive effect of common share equivalents 159,396 156,440 145,403 41,704 35,193 34,074 30,745 28,117 26,998 2,891 2,720 2,428 234,736 222,470 208,903 22,405 19,685 17,344 (1,663) (1,704) (1,400) 20,742 17,981 15,944 (4,973) (3,742) (3,562) 15,769 14,239 12,382 (366) (400) (396) $ 15,403 $ 13,839 $ 11,986 $ 16.23 $ 14.55 $ 12.45 $ 16.03 $ 14.33 $ 12.19 949 12 951 15 963 20 961 966 983 8 10 6